Account-creators
1,040
edits
Jensflorian (talk | contribs) (→IHC) |
Jensflorian (talk | contribs) (→gangliocytoma: update according WHO2017) |
||
(15 intermediate revisions by the same user not shown) | |||
Line 97: | Line 97: | ||
Classification: | Classification: | ||
#Microadenoma <= 1 cm. | #Microadenoma <= 1 cm. | ||
#Macroadenoma | #Macroadenoma 1-4 cm. | ||
#Giant adenoma > 4cm. | #Giant adenoma > 4cm. | ||
Line 114: | Line 114: | ||
Imaging: | Imaging: | ||
*Sellar enlargement. | *Sellar enlargement. | ||
*Bone erosion | *Bone erosion, invasive growth esp. cavernous sinus (35-45%). | ||
*Inhomogenous signal in T1w MRI. | *Inhomogenous signal in T1w MRI. | ||
Line 145: | Line 145: | ||
*Loss of fibrous stroma. | *Loss of fibrous stroma. | ||
**The cells of a normal (anterior) pituitary are nested. | **The cells of a normal (anterior) pituitary are nested. | ||
*Basophilic cells (corticotrophs). | |||
*Eosinophilic cells(somatotrophs). | |||
Notes: | Notes: | ||
*Smears very well.<ref>MUN. 24 November 2010.</ref> | *Smears very well.<ref>MUN. 24 November 2010.</ref> | ||
The WHO 2017 Classification of tumours of endocrine organs recoginizes following tumours:<ref>{{Cite journal | last1 = Lopes | first1 = MBS. | title = The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. | journal = Acta Neuropathol | volume = 134 | issue = 4 | pages = 521-535 | month = Oct | year = 2017 | doi = 10.1007/s00401-017-1769-8 | PMID = 28821944 }}</ref> | |||
{| class="wikitable sortable" style="margin-left:auto;margin-right:auto" | |||
! Adenoma type | |||
! subtypes | |||
! Hormone secretion | |||
! Transcription factor | |||
|- | |||
| Somatotroph adenoma | |||
| Densely and sparsely granulated adenoma, Mammosomatotroph adenoma, Mixed GH and PRL adenoma | |||
| GH +/- PRL | |||
| PIT1 | |||
|- | |||
| Lactotroph adenoma | |||
| Densely and sparsely granulated adenoma, Acidophilic stem cell adenoma | |||
| PRL | |||
| PIT1, [[Estrogen receptor|ER]] | |||
|- | |||
| Thyrotroph adenoma | |||
| | |||
| TSH | |||
| PIT1, [[Estrogen receptor|ER]] | |||
|- | |||
| Corticotroph adenoma | |||
| Densely and sparsely granulated adenoma, Crooke cell adenoma | |||
| ACTH,CAM 5.2 | |||
| TPIT | |||
|- | |||
| Gonadotroph adenoma | |||
| Sparsely granulated adenoma | |||
| FSH, LH or a-Subunit | |||
| SF1, [[Estrogen receptor|ER]], GATA2 | |||
|- | |||
| Null cell adenoma | |||
| | |||
| None | |||
| None | |||
|} | |||
Other tumours may be classified as plurhormonal or double adenomas or as adenomas with unusual IHC combination. | |||
====Images==== | ====Images==== | ||
Line 170: | Line 215: | ||
Crooke_HE_40x.jpg | Crooke cell adenoma, HE (WC/Marvin101) | Crooke_HE_40x.jpg | Crooke cell adenoma, HE (WC/Marvin101) | ||
File:Crooke Cytokeratins.jpg | Crooke cell adenoma, panCK (WC/Marvin101) | File:Crooke Cytokeratins.jpg | Crooke cell adenoma, panCK (WC/Marvin101) | ||
HE_fibrosis_pituitary_adenoma.jpg | Fibrosis in pituitary adenoma. | |||
</gallery> | </gallery> | ||
Line 180: | Line 226: | ||
*TSH - [[Hyperthyroidism]] | *TSH - [[Hyperthyroidism]] | ||
*GH - [[Acromegaly]]. | *GH - [[Acromegaly]]. | ||
*Prolactin -Galactorrhea, Amenorrhea, Gynecomastia. | *Prolactin -Galactorrhea, Amenorrhea, Gynecomastia. Golgi staining pattern in sparsely granulated cases. | ||
*ACTH - [[Cushing syndrome]]. | *ACTH - [[Cushing syndrome]]. | ||
*PIT-1: stains somatotrophs, lactotrophs and thyrothrops. | *PIT-1: stains somatotrophs, lactotrophs and thyrothrops. | ||
Line 186: | Line 232: | ||
*SF1: stains gonadotrophs. | *SF1: stains gonadotrophs. | ||
*Chromogranin A +ve | *Chromogranin A +ve | ||
*Synaptophysin +ve | *Synaptophysin strongly +ve (except lactotrophs) | ||
*CAM5.2: fibrous bodies in sparsely granulated somatotroph adenoma, Ring-like staining in Crooke cell adenoma. | |||
*MIB-1: Usu less than 3%. | |||
Note: | |||
Null-cell adenoma must be hormone immunonegative and negative for transcription factors. | |||
===Variants=== | ===Variants=== | ||
*Corticotroph adenomas exhibiting Crooke's hyaline change: agressive course.<ref>{{Cite journal | last1 = George | first1 = DH. | last2 = Scheithauer | first2 = BW. | last3 = Kovacs | first3 = K. | last4 = Horvath | first4 = E. | last5 = Young | first5 = WF. | last6 = Lloyd | first6 = RV. | last7 = Meyer | first7 = FB. | title = Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. | journal = Am J Surg Pathol | volume = 27 | issue = 10 | pages = 1330-6 | month = Oct | year = 2003 | doi = | PMID = 14508394 }}</ref> | *Corticotroph adenomas exhibiting Crooke's hyaline change: agressive course.<ref>{{Cite journal | last1 = George | first1 = DH. | last2 = Scheithauer | first2 = BW. | last3 = Kovacs | first3 = K. | last4 = Horvath | first4 = E. | last5 = Young | first5 = WF. | last6 = Lloyd | first6 = RV. | last7 = Meyer | first7 = FB. | title = Crooke's cell adenoma of the pituitary: an aggressive variant of corticotroph adenoma. | journal = Am J Surg Pathol | volume = 27 | issue = 10 | pages = 1330-6 | month = Oct | year = 2003 | doi = | PMID = 14508394 }}</ref> | ||
*Acidophilic stem cell adenomas: large, locally invasive adenoma with low GH activity. <ref>{{Cite journal | last1 = Horvath | first1 = E. | last2 = Kovacs | first2 = K. | last3 = Singer | first3 = W. | last4 = Smyth | first4 = HS. | last5 = Killinger | first5 = DW. | last6 = Erzin | first6 = C. | last7 = Weiss | first7 = MH. | title = Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases. | journal = Cancer | volume = 47 | issue = 4 | pages = 761-71 | month = Feb | year = 1981 | doi = | PMID = 6261917 }}</ref> | *Acidophilic stem cell adenomas: large, locally invasive adenoma with low GH activity. <ref>{{Cite journal | last1 = Horvath | first1 = E. | last2 = Kovacs | first2 = K. | last3 = Singer | first3 = W. | last4 = Smyth | first4 = HS. | last5 = Killinger | first5 = DW. | last6 = Erzin | first6 = C. | last7 = Weiss | first7 = MH. | title = Acidophil stem cell adenoma of the human pituitary: clinicopathologic analysis of 15 cases. | journal = Cancer | volume = 47 | issue = 4 | pages = 761-71 | month = Feb | year = 1981 | doi = | PMID = 6261917 }}</ref> | ||
*Sparsely granulated somatotroph adenomas are more invasive than other variants and respond less to medical treatment. <ref>{{Cite journal | last1 = Kato | first1 = M. | last2 = Inoshita | first2 = N. | last3 = Sugiyama | first3 = T. | last4 = Tani | first4 = Y. | last5 = Shichiri | first5 = M. | last6 = Sano | first6 = T. | last7 = Yamada | first7 = S. | last8 = Hirata | first8 = Y. | title = Differential expression of genes related to drug responsiveness between sparsely and densely granulated somatotroph adenomas. | journal = Endocr J | volume = 59 | issue = 3 | pages = 221-8 | month = | year = 2012 | doi = | PMID = 22200580 }}</ref> | |||
* Lactotroph adenomas in men may show aggressive clinical behavior. <ref>{{Cite journal | last1 = Delgrange | first1 = E. | last2 = Vasiljevic | first2 = A. | last3 = Wierinckx | first3 = A. | last4 = François | first4 = P. | last5 = Jouanneau | first5 = E. | last6 = Raverot | first6 = G. | last7 = Trouillas | first7 = J. | title = Expression of estrogen receptor alpha is associated with prolactin pituitary tumor prognosis and supports the sex-related difference in tumor growth. | journal = Eur J Endocrinol | volume = 172 | issue = 6 | pages = 791-801 | month = Jun | year = 2015 | doi = 10.1530/EJE-14-0990 | PMID = 25792376 }}</ref> | |||
*Poorly differentiated PIT-1 positive adenomas may show aggresive growth. <ref> {{Cite journal | last1 = Mete | first1 = O. | last2 = Gomez-Hernandez | first2 = K. | last3 = Kucharczyk | first3 = W. | last4 = Ridout | first4 = R. | last5 = Zadeh | first5 = G. | last6 = Gentili | first6 = F. | last7 = Ezzat | first7 = S. | last8 = Asa | first8 = SL. | title = Silent subtype 3 pituitary adenomas are not always silent and represent poorly differentiated monomorphous plurihormonal Pit-1 lineage adenomas. | journal = Mod Pathol | volume = 29 | issue = 2 | pages = 131-42 | month = Feb | year = 2016 | doi = 10.1038/modpathol.2015.151 | PMID = 26743473 }}</ref> | |||
==Pituitary blastoma== | |||
* New entity introduced in 2017<ref>{{Cite journal | last1 = Lopes | first1 = MBS. | title = The 2017 World Health Organization classification of tumors of the pituitary gland: a summary. | journal = Acta Neuropathol | volume = 134 | issue = 4 | pages = 521-535 | month = Oct | year = 2017 | doi = 10.1007/s00401-017-1769-8 | PMID = 28821944 }}</ref> | |||
* Epithelial glands with rosette-like formations resembling immature Rathke epithelium. | |||
* Synaptophysin +ve, usu. ACTH+ve | |||
* DICER1 mutations<ref>{{Cite journal | last1 = de Kock | first1 = L. | last2 = Sabbaghian | first2 = N. | last3 = Plourde | first3 = F. | last4 = Srivastava | first4 = A. | last5 = Weber | first5 = E. | last6 = Bouron-Dal Soglio | first6 = D. | last7 = Hamel | first7 = N. | last8 = Choi | first8 = JH. | last9 = Park | first9 = SH. | title = Pituitary blastoma: a pathognomonic feature of germ-line DICER1 mutations. | journal = Acta Neuropathol | volume = 128 | issue = 1 | pages = 111-22 | month = Jul | year = 2014 | doi = 10.1007/s00401-014-1285-z | PMID = 24839956 }}</ref> | |||
==Pituitary carcinoma== | ==Pituitary carcinoma== | ||
Line 232: | Line 292: | ||
{{Main|Craniopharyngioma}} | {{Main|Craniopharyngioma}} | ||
== | ==Gangliocytoma== | ||
* Neuronal cells in abundant neuropil. | * Neuronal cells in abundant neuropil. | ||
* S-100, Synaptophysin +ve. | * S-100, Synaptophysin +ve. | ||
* Isolated sellar cases are very rare. | |||
Image: [[https://twitter.com/sty_md/status/664676241111252992]] | Image: [[https://twitter.com/sty_md/status/664676241111252992]] | ||
==Mixed Gangliocytoma-adenoma== | |||
AKA: ganglioneuroma, pituitary adenoma with neuronal choristoma (PANCH) | |||
*Neuronal cells mixed with pituitary adenoma cells. | |||
* Approx. 0.25% of all pituitary adenomas. | |||
* Association with somatotroph adenomas (acromegaly). | |||
==Pituicytoma== | ==Pituicytoma== |